Aequs Limited has appointed Mr. Ravi Kumar Assudani as Head of Engineering – Consumer Business and designated him as Senior Management Personnel (SMP) of the Company, effective May 11, 2026. The appointment was approved by the Board of Directors through a circular resolution passed on May 11, 2026, based on the recommendation of the Nomination and Remuneration Committee, in compliance with Regulation 30 of the SEBI Listing Regulations.

Key Appointment Details

The following table summarizes the key details of this leadership appointment:

Professional Profile

Mr. Assudani brings over 16 years of experience in manufacturing design and operations. Most recently, he served in a senior leadership role at Apple Inc., where he led global tooling and manufacturing initiatives across multiple product lines. He holds a Master of Science in Mechanical Engineering from Stanford University and a Bachelor of Technology from the Indian Institute of Technology Guwahati. His expertise spans advanced manufacturing technologies, global supply chain management, and large-scale program execution.

Leadership Strengthening

The appointment underscores Aequs Limited's focus on strengthening its engineering leadership within the Consumer Business segment. His extensive background, including his tenure at Apple Inc. and academic credentials from globally recognized institutions, is expected to bring significant domain expertise to the role. This addition to the leadership team reflects the company's commitment to building a robust engineering function for its consumer-facing operations.

The Nomination and Remuneration Committee ("NRC") of the Board of Directors of Aequs Limited has approved the grant of 750,000 Employee Stock Options ("Stock Options") under the Aequs Employee Stock Option Plan 2025 ("ESOP 2025") to eligible employees of the Company on May 11, 2026. The disclosure has been made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and is also in accordance with SEBI Circular No. HO/CFD/PoD2/I/3762/2026 dated January 30, 2026.

Key Details of the ESOP Grant

The grant covers 750,000 equity shares of face value INR 10/- each, with the exercise price set at INR 203.50 per Stock Option. This exercise price represents the last traded price of the equity shares of Aequs Limited on the National Stock Exchange of India Limited — the stock exchange with the highest trading volume — as on May 08, 2026, being the trading day immediately preceding the date of grant on May 11, 2026.

The following table summarises the key parameters of the ESOP 2025 grant:

Vesting and Exercise Conditions

The Stock Options granted under ESOP 2025 are subject to a minimum vesting period of one year from the date of grant, with the full vesting schedule specified in the individual grant letters issued to eligible employees. Upon fulfilment of the applicable vesting conditions, vested options must be exercised within three years from the date of respective vesting. Once vested, each Stock Option entitles the holder to acquire one equity share of Aequs Limited upon payment of the exercise price and applicable taxes, in accordance with the terms and conditions of ESOP 2025.

Eligibility and Scheme Compliance

The grant of Stock Options is based upon the eligibility criteria as specified under ESOP 2025. The scheme is in compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Assuming all granted options are vested and exercised, a total of 750,000 equity shares of face value INR 10/- each would arise as a result. Metrics such as options vested, options exercised, money realised by exercise, options lapsed, and diluted earnings per share are not applicable at this stage, as the current disclosure pertains solely to the grant of Stock Options under ESOP 2025.

Disclosure and Regulatory Compliance

The intimation has been filed under Regulation 30 of the SEBI Listing Regulations and is also in accordance with SEBI Circular No. HO/CFD/PoD2/I/3762/2026 dated January 30, 2026. The announcement is available on the Company's investor relations webpage. The disclosure was signed by Ravi Mallikarjun Hugar, Company Secretary and Compliance Officer (Membership Number: A20823), on May 11, 2026.